These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

388 related articles for article (PubMed ID: 30085065)

  • 1. Single-station skip-N2 disease: good prognosis in resected non-small-cell lung cancer (long-term results in skip-N2 disease).
    Yazgan S; Ucvet A; Gursoy S; Samancilar O; Yagci T
    Interact Cardiovasc Thorac Surg; 2019 Feb; 28(2):247-252. PubMed ID: 30085065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term survival of patients with pN2 lung cancer according to the pattern of lymphatic spread.
    Legras A; Mordant P; Arame A; Foucault C; Dujon A; Le Pimpec Barthes F; Riquet M
    Ann Thorac Surg; 2014 Apr; 97(4):1156-62. PubMed ID: 24582052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survival benefit of skip metastases in surgically resected N2 non-small cell lung cancer: A multicenter observational study of a large cohort of the Chinese patients.
    Li X; Li X; Fu X; Liu L; Liu Y; Zhao H; Li Y; Hu J; Xu L; Liu D; Yang H; Zhang X
    Eur J Surg Oncol; 2020 Oct; 46(10 Pt A):1874-1881. PubMed ID: 31902592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic factors for survival in patients with completely resected pN2 non-small-cell lung cancer.
    Sezen CB; Aksoy Y; Sonmezoglu Y; Citak N; Saydam O; Metin M
    Acta Chir Belg; 2021 Feb; 121(1):23-29. PubMed ID: 31437115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic factors after surgical resection of N1 non-small cell lung cancer.
    Mordant P; Pricopi C; Legras A; Arame A; Foucault C; Dujon A; Le Pimpec-Barthes F; Riquet M
    Eur J Surg Oncol; 2015 May; 41(5):696-701. PubMed ID: 25454825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical analysis of skip N2 metastases in stage IIIA non-small cell lung cancer].
    Liu K; Chen HL; You QS; Huang JF; Wang H
    Ai Zheng; 2009 Jul; 28(7):725-9. PubMed ID: 19624899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence, Risk Factors, and Analysis of Survival of Unexpected N2 Disease in Stage I Non-Small Cell Lung Cancer.
    Fiorelli A; Sagan D; Mackiewicz L; Cagini L; Scarnecchia E; Chiodini P; Caronia FP; Puma F; Santini M; Ragusa M
    Thorac Cardiovasc Surg; 2015 Oct; 63(7):558-67. PubMed ID: 25629458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of skip metastasis to mediastinal lymph nodes in non-small cell lung cancer.
    Prenzel KL; Mönig SP; Sinning JM; Baldus SE; Gutschow CA; Grass G; Schneider PM; Hölscher AH
    J Surg Oncol; 2003 Apr; 82(4):256-60. PubMed ID: 12672010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Skip mediastinal nodal metastases in the IIIa/N2 non-small cell lung cancer.
    Ilic N; Petricevic A; Arar D; Kotarac S; Banovic J; Ilic NF; Tripkovic A; Grandic L
    J Thorac Oncol; 2007 Nov; 2(11):1018-21. PubMed ID: 17975493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic factors after complete resection of pN2 non-small cell lung cancer.
    Sonobe M; Date H; Wada H; Okubo K; Hamakawa H; Teramukai S; Matsumura A; Nakagawa T; Sumitomo S; Miyamoto Y; Okumura N; Takeo S; Kawakami K; Aoki M; Kosaka S;
    J Thorac Cardiovasc Surg; 2013 Oct; 146(4):788-95. PubMed ID: 23810113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A proposal for combination of total number and anatomical location of involved lymph nodes for nodal classification in non-small cell lung cancer.
    Saji H; Tsuboi M; Shimada Y; Kato Y; Yoshida K; Nomura M; Matsubayashi J; Nagao T; Kakihana M; Usuda J; Kajiwara N; Ohira T; Ikeda N
    Chest; 2013 Jun; 143(6):1618-1625. PubMed ID: 23740149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Skip mediastinal lymph node metastasis and lung cancer: a particular N2 subgroup with a better prognosis.
    Riquet M; Assouad J; Bagan P; Foucault C; Le Pimpec Barthes F; Dujon A; Danel C
    Ann Thorac Surg; 2005 Jan; 79(1):225-33. PubMed ID: 15620948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of subcarinal station in non-small cell lung cancer with T1-3 N2 disease.
    Iwasaki A; Shirakusa T; Miyoshi T; Hamada T; Enatsu S; Maekawa S; Hiratsuka M
    Thorac Cardiovasc Surg; 2006 Feb; 54(1):42-6. PubMed ID: 16485188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Skip metastasis in nonsmall cell lung carcinoma: predictive markers and isolated tumor cells in N1 lymph nodes.
    Prenzel KL; Baldus SE; Mönig SP; Tack D; Sinning JM; Gutschow CA; Grass G; Schneider PM; Dienes HP; Hölscher AH
    Cancer; 2004 May; 100(9):1909-17. PubMed ID: 15112272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Time to refine N2 staging? cN2α and cN2β based on local regional involvement provide a more accurate prognosis in surgically treated IIIA non-small-cell lung cancer than N2 alone or the number of node stations involved.
    Matsunaga T; Suzuki K; Takamochi K; Oh S
    Eur J Cardiothorac Surg; 2014 Jul; 46(1):86-91. PubMed ID: 24321998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation of pN2 sub-classifications in patients with pathological stage IIIA N2 non-small cell lung cancer.
    Nakagiri T; Sawabata N; Funaki S; Inoue M; Kadota Y; Shintani Y; Okumura M
    Interact Cardiovasc Thorac Surg; 2011 May; 12(5):733-8. PubMed ID: 21297135
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction of lymph node status in completely resected IIIa/N2 small cell lung cancer: importance of subcarinal station metastases.
    Qiao R; Zhong R; Xu J; Zhang Y; Zhang B; Wang S; Lou Y; Chen D; Chang Q; Zhao Y; Han B
    J Cardiothorac Surg; 2019 Mar; 14(1):63. PubMed ID: 30925891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of risk factors for skip lymphatic metastasis and their prognostic value in operated N2 non-small-cell lung carcinoma.
    Benoit L; Anusca A; Ortega-Deballon P; Cheynel N; Bernard A; Favre JP
    Eur J Surg Oncol; 2006 Jun; 32(5):583-7. PubMed ID: 16621424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison between lymph node station- and zone-based classification for the future revision of node descriptors proposed by the International Association for the Study of Lung Cancer in surgically resected patients with non-small-cell lung cancer.
    Yun JK; Lee GD; Choi S; Kim HR; Kim YH; Kim DK; Park SI
    Eur J Cardiothorac Surg; 2019 Nov; 56(5):849-857. PubMed ID: 31168596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidermal growth factor receptor mutations are linked to skip N2 lymph node metastasis in resected non-small-cell lung cancer adenocarcinomas.
    Guerrera F; Renaud S; Tabbó F; Voegeli' AC; Filosso PL; Legrain M; Boita M; Schaeffer M; Beau-Faller M; Ruffini E; Falcoz PE; Inghirami G; Oliaro A; Massard G
    Eur J Cardiothorac Surg; 2017 Apr; 51(4):680-688. PubMed ID: 28329143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.